Lisa Robins, CEO of Patients Australia, and Dr Nick Coatsworth, the organisation's Health Reform Ambassador, spoke with BPDInsights about a recent national survey that provides detailed insights into why uptake remains stubbornly low. …
Patients Australia survey reveals targets to address barriers to biosimilar uptake
March 31, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Australian company secures European approval for rare disease treatment
August 26, 2026 - - Latest News -
Australia cannot deliver meaningful change until the levers of power are rebalanced
August 26, 2026 - - Latest News -
Insurers warn cut could hit Australians most likely to need cancer care
August 25, 2026 - - Latest News -
Australian study finds maternal RSV vaccination offers strong protection for infants
August 25, 2026 - - Latest News -
Acrux brings experienced clinical leader aboard to advance testosterone program
August 24, 2026 - - Australian Biotech -
Avecho moves to deepen global partnering push as CBD insomnia program advances
August 24, 2026 - - Australian Biotech -
July recommendations across oncology, rare disease and chronic care
August 24, 2026 - - Latest News